Board Chair · NED · Adviser

Capital and governance,
at the level of the work.

Thirty years across strategy, capital and governance. A decade focused on growth-stage healthcare, life sciences, medtech, diagnostics, digital health, data, software and AI. Independent. Commercially direct. Analytically rigorous.

Pedigree

McKinsey · Lazard · Macquarie

Education

Wharton MBA · ESSEC

Director

GAICD · 2007

Based

Sydney

Operates

Australia · Asia

002

Approach

A board contribution rooted in execution.

{C.summaryProse.map((p, i) =>

{p}

)}

Track record: 4Cyte Pathology from concept to {'>'}$600m revenue; Prospection through $65m across two rounds and into the US and Japan; Genetic Signatures through CEO transition and two raises; advising Heidi, used by 370,000 clinicians in 10 million consultations per month.

003

What I bring

Four pillars.

{C.pillars.map((p, i) =>

P / 0{i + 1}

{p.label}

{p.body}

)}

004

Sectors

Where the work concentrates.

{C.sectors.map((s) =>

{s.code} ·

{s.name}

{s.note}

)}

{[ { n: '005', id: 'current', l: 'Current', t: 'Boards & advisory · today.', rows: C.current }, { n: '006', id: 'prior', l: 'Prior', t: 'Selected previous boards and advisory roles.', rows: C.prior }, { n: '007', id: 'background', l: 'Background', t: 'Earlier executive career.', rows: C.executive }]. map((s) =>

{s.n}

{s.l}

{s.t}

{s.rows.map((r, i) =>

{r.from}
{r.to}

{r.role}

{r.org}{r.ticker && {r.ticker}}

{r.note}

{r.where}

)}

008

Credentials

Independent judgement, on the record.

{C.credentials.map((c, i) =>

{c.from} — {c.to}

{c.title}

{c.note}

)}

{C.education.map((e, i) =>

{e.school}

{e.line}

)}

009

Writings

Selected articles and commentary.

{C.writings.map((w, i) =>

{w.date}

{w.title}

{w.outlet}

)}

010

CONTACT

Considering a board appointment or strategic advisory engagement?

{C.contact.email}

{C.contact.linkedin}

Phone

{C.contact.phone}

Stephane D. Chatonsky v.04.26 · MMXXVI

Capital and governance,at the level of the work.